Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.98 USD | -2.12% | -4.16% | +38.34% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.34% | 2.46B | |
+18.69% | 3,317B | |
+20.47% | 95.04B | |
+19.87% | 89.51B | |
+50.38% | 57.5B | |
-20.45% | 49.11B | |
+37.92% | 48.55B | |
+88.35% | 43.81B | |
-35.60% | 39.87B | |
-3.47% | 27.19B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating